trending Market Intelligence /marketintelligence/en/news-insights/trending/3gHsHPQtAuQpgHaUFf_jtA2 content esgSubNav
In This List

Israel's Taro completes $250M share buyback program

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Israel's Taro completes $250M share buyback program

Taro Pharmaceutical Industries Ltd. completed a $250 million share buyback program which was announced in November 2016.

The Israeli pharmaceutical company bought back 2,493,378 ordinary shares at an average price of $100.28 per share.